LONDON, May 15, 2025 /PRNewswire/ — Curaleaf International, part of Curaleaf Holdings, Inc. (TSX:CURA) a leading international provider of medical cannabis products, today announced the launch of Curaleaf branded products in Australia. This announcement marks the expansion of Curaleaf’s presence in one of the world’s fastest growing medical cannabis markets and underscores its commitment to local collaboration, clinical integrity, and patient care.
The initial product offering, comprising four cannabis flower strains, will be distributed via Canngea, a licensed Australian manufacturer and wholesaler with a wealth of experience in medical cannabis. This partnership supports Curaleaf’s vision to be the world’s leading cannabis company by consistently delivering superior products and services.
Over the coming months, patients and healthcare professionals in Australia can look forward to a broader portfolio and further innovative…
